Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis

✍ Scribed by Jacques Planas; Enrique Trilla; Carles Raventós; Lluis Cecchini; Anna Orsola; Carles Salvador; Jose Placer; Gloria Encabo; Juan Morote

• Book ID: 109055902
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 159 KB
• Volume: 104
• Category: Article
• ISSN: 1464-4096
• DOI: 10.1111/j.1464-410x.2009.08622.x